| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/08/2001 | CA2382953A1 Dna encoding the human serine protease c-e |
| 03/08/2001 | CA2382789A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | CA2382611A1 Compositions for stimulating cytokine secretion and inducing an immune response |
| 03/08/2001 | CA2382562A1 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | CA2382556A1 Coformulation methods and their products |
| 03/08/2001 | CA2382551A1 Plant extract mixtures and their uses |
| 03/08/2001 | CA2382499A1 Method for coupling molecules |
| 03/08/2001 | CA2382427A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | CA2382345A1 Extended duration light activated cancer therapy |
| 03/08/2001 | CA2382303A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | CA2382120A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 03/08/2001 | CA2382100A1 Dosages for treatment with anti-erbb2 antibodies |
| 03/08/2001 | CA2381821A1 Substituted indolinones, their manufacture and their use as medicaments |
| 03/08/2001 | CA2381553A1 Fused pyrrolecarboxamides: gaba brain receptor ligands |
| 03/08/2001 | CA2381239A1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes |
| 03/08/2001 | CA2380355A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2379421A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 03/08/2001 | CA2378298A1 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators |
| 03/07/2001 | EP1081155A2 N6 heterocyclic substituted adenosine derivatives |
| 03/07/2001 | EP1081146A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081142A2 Novel N-Aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1081135A2 1H-indole-3-glyoxylamide spla2 inhibitors |
| 03/07/2001 | EP1080729A1 Cervical ripening agent and cervical ripening method |
| 03/07/2001 | EP1080728A1 Prostaglandin ep4 receptor agonist and treatment method |
| 03/07/2001 | EP1080726A1 Agents for relieving side effects |
| 03/07/2001 | EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 03/07/2001 | EP1080203A2 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
| 03/07/2001 | EP1080200A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 03/07/2001 | EP1080190A1 Calmodulin related protein |
| 03/07/2001 | EP1080186A2 Method for altering the activity of proteins of the pka signaling pathway |
| 03/07/2001 | EP1080185A2 Myelin basic protein peptides and uses thereof |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080111A2 The induction of antiobiotic peptides by lait (scd14) protein |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080104A1 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 03/07/2001 | EP1080094A1 G-csf mimetics |
| 03/07/2001 | EP1080093A1 G-csf mimetics |
| 03/07/2001 | EP1080092A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 03/07/2001 | EP1080091A1 Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| 03/07/2001 | EP1080087A1 Novel 2-alkyl substituted imidazole compounds |
| 03/07/2001 | EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080074A1 New heterocyclically substituted amides, their production and their use |
| 03/07/2001 | EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1080066A1 Bioreductive cytotoxic agents |
| 03/07/2001 | EP1080057A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene |
| 03/07/2001 | EP1079863A1 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation |
| 03/07/2001 | EP1079856A1 Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 03/07/2001 | EP1079854A1 Compositions and methods of modulating an immune response to an antigen |
| 03/07/2001 | EP1079852A1 Composition based on pentoxifylline and anticytokin |
| 03/07/2001 | EP1079849A2 Use of hmg proteins for the preparation of medicaments having cytotoxic activity |
| 03/07/2001 | EP1079848A1 Angiostatin receptor |
| 03/07/2001 | EP1079847A2 Osteoporosis treatment |
| 03/07/2001 | EP1079846A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 03/07/2001 | EP1079843A2 USE OF g(a)1 g(b) INTEGRIN RECEPTOR INHIBITORS AND TGF- g(b)1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
| 03/07/2001 | EP1079837A1 Method of inhibiting membrane-type matrix metalloproteinase |
| 03/07/2001 | EP1079835A1 Pyrazinone thrombin inhibitors |
| 03/07/2001 | EP1079832A1 Use of vitamin pp compounds |
| 03/07/2001 | EP1079830A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE |
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP1079824A1 Triterpene compositions and methods for use thereof |
| 03/07/2001 | EP1079792A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases |
| 03/07/2001 | EP1079791A2 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO |
| 03/07/2001 | EP1079763A2 Serotonergic 5ht 7? receptor compounds for treating ocular and cns disorders |
| 03/07/2001 | EP0934295B1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 03/07/2001 | EP0840732B1 Substituted benzolactam compounds as substance p antagonists |
| 03/07/2001 | EP0783505B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 03/07/2001 | EP0777650B1 Biphenylamide derivatives as 5ht 1d antagonists |
| 03/07/2001 | EP0734379B1 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof |
| 03/07/2001 | EP0730579B1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 03/07/2001 | CN1286726A Histamine and serotonin binding molecules |
| 03/07/2001 | CN1286693A 11 'beta'-halogen-7 'alpha'-substd estratrienes, method for producing pharmaceutical preparations contg. said 11 'beta'-halogen-7 'alpha'-substd estratrienes and use of same for producing medicaments |
| 03/07/2001 | CN1286690A Compounds useful for inhibition of farnesyl protein transferase |
| 03/07/2001 | CN1286632A Use of purine nucleosides for modulating axonal outgrowth of central nervous system neurons |
| 03/07/2001 | CN1286258A Purine L-nucleoside, analogs and use thereof |
| 03/07/2001 | CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286105A Moxiburning medicine for acupoint therapy |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062868C Total esculentoside and treating application to endometriosis |
| 03/07/2001 | CN1062865C Process for production of amidinobenzofuran and amidinobenzothiophen derivs. and salt thereof |
| 03/07/2001 | CN1062758C Plaster for treating diseases caused by deficiency of kidney |
| 03/07/2001 | CN1062735C Use of bisphosphonic acid derivs. for preparation of drugs intended for promoting bone repair |
| 03/07/2001 | CN1062732C Use of compositions based on alpha-pyrones for inducing and stimulating hair growth and/or retarding hair loss |
| 03/06/2001 | US6197982 Vitamin D analogues |
| 03/06/2001 | US6197975 7-azabicyclo(2.2.1)heptane-7-carbonyl-substituted 2-phenylindole derivatives; sexual disorders; anticarcinogenic agents |
| 03/06/2001 | US6197959 Piperidine derivatives |
| 03/06/2001 | US6197930 Polypeptide for use in organ preservation, cryopreservation, for surgical pretreatment to prevent injury due to inflammation; antiischemic agents |
| 03/06/2001 | US6197828 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 03/06/2001 | US6197826 α-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation |
| 03/06/2001 | US6197822 Neuropeptide antagonists |
| 03/06/2001 | US6197812 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 03/06/2001 | US6197811 Synthetic derivatives of phomalactone, a known compound obtainable by fermentation of the fungus phomopsis sp, have activity as inhibitors of cytokine production in treatment of disorders requiring immunosuppression, for example |
| 03/06/2001 | US6197800 Hypotensive agents; cardiovascular disorders |
| 03/06/2001 | US6197797 Cyanoguanidines as cell proliferation inhibitors |
| 03/06/2001 | US6197794 Antiinflamamtory agents; immunology diseases |
| 03/06/2001 | US6197786 Anticholesterol agents |
| 03/06/2001 | US6197785 Cardiovascular disorders |